MX2009010372A - Nueva composicion basada en oxima de cholest-4-en-3ona. - Google Patents
Nueva composicion basada en oxima de cholest-4-en-3ona.Info
- Publication number
- MX2009010372A MX2009010372A MX2009010372A MX2009010372A MX2009010372A MX 2009010372 A MX2009010372 A MX 2009010372A MX 2009010372 A MX2009010372 A MX 2009010372A MX 2009010372 A MX2009010372 A MX 2009010372A MX 2009010372 A MX2009010372 A MX 2009010372A
- Authority
- MX
- Mexico
- Prior art keywords
- oil
- cholest
- oxime
- ene
- novel composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- NYOXRYYXRWJDKP-UHFFFAOYSA-N cholestenone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 NYOXRYYXRWJDKP-UHFFFAOYSA-N 0.000 title abstract 2
- 150000002923 oximes Chemical class 0.000 title abstract 2
- 239000008159 sesame oil Substances 0.000 abstract 3
- 235000011803 sesame oil Nutrition 0.000 abstract 3
- 239000003921 oil Substances 0.000 abstract 2
- 235000019198 oils Nutrition 0.000 abstract 2
- 239000004006 olive oil Substances 0.000 abstract 2
- 235000008390 olive oil Nutrition 0.000 abstract 2
- 239000003549 soybean oil Substances 0.000 abstract 2
- 235000012424 soybean oil Nutrition 0.000 abstract 2
- 235000012343 cottonseed oil Nutrition 0.000 abstract 1
- 239000002385 cottonseed oil Substances 0.000 abstract 1
- 229940057917 medium chain triglycerides Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Un objeto de la invención es una nueva composición, particularmente una composición farmacéutica que comprende la oxima de colest-4-en-3-ona y un aceite seleccionado de aceite de sésamo, aceite de oliva, aceite de soya, aceite de algodón, o de una mezcla de triglicéridos comerciales de cadena media (ESTASAN(r), MYGLIOL(r)), o de una mezcla de estos aceites, preferiblemente de aceite de sésamo, aceite de oliva o aceite de soya, aun más preferiblemente aceite de sésamo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0702247A FR2914188B1 (fr) | 2007-03-28 | 2007-03-28 | Nouvelle composition a base d'oxime de cholest-4-en-3-one |
| PCT/FR2008/000406 WO2008142231A2 (fr) | 2007-03-28 | 2008-03-26 | Nouvelle composition à base d'oxime de cholest-4-èn-3-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009010372A true MX2009010372A (es) | 2009-10-19 |
Family
ID=38617247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009010372A MX2009010372A (es) | 2007-03-28 | 2008-03-26 | Nueva composicion basada en oxima de cholest-4-en-3ona. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100099652A1 (es) |
| EP (1) | EP2124961B1 (es) |
| JP (1) | JP5519488B2 (es) |
| AU (1) | AU2008252830B2 (es) |
| BR (1) | BRPI0808945A2 (es) |
| CA (1) | CA2680433C (es) |
| DK (1) | DK2124961T3 (es) |
| ES (1) | ES2454268T3 (es) |
| FR (1) | FR2914188B1 (es) |
| MX (1) | MX2009010372A (es) |
| NZ (1) | NZ579632A (es) |
| PL (1) | PL2124961T3 (es) |
| PT (1) | PT2124961E (es) |
| RU (1) | RU2462250C2 (es) |
| WO (1) | WO2008142231A2 (es) |
| ZA (1) | ZA200906271B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2874923B1 (fr) * | 2004-09-07 | 2006-10-27 | Trophos Sa | Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation |
| FR2919180B1 (fr) * | 2007-07-25 | 2009-11-27 | Trophos | Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants |
| DE102010015143A1 (de) * | 2010-04-16 | 2011-10-20 | Cts Chemical Industries Ltd. | Stabile flüssige ölige gebrauchsfertige Formulierungen, Herstellung davon und Verwendung davon |
| WO2012069150A2 (en) | 2010-11-22 | 2012-05-31 | Powerpore Gmbh | Cytoprotectant agents for the prevention of drug-associated side-effects |
| FR2979239A1 (fr) * | 2011-08-25 | 2013-03-01 | Trophos | Liposome comprenant au moins un derive de cholesterol |
| BR112018009281B1 (pt) | 2015-11-12 | 2023-10-31 | F. Hoffmann-La Roche Ag | Composições para tratar atrofia muscular espinhal e seu uso |
| JP6872550B2 (ja) | 2015-12-10 | 2021-05-19 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 架橋されたピペリジン誘導体 |
| MX382671B (es) | 2015-12-10 | 2025-03-13 | Ptc Therapeutics Inc | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington |
| JP2019517516A (ja) | 2016-06-03 | 2019-06-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｓｍａの新規な処置 |
| WO2018073141A1 (en) | 2016-10-18 | 2018-04-26 | F. Hoffmann-La Roche Ag | New composition for treating sma |
| JP7376471B2 (ja) | 2017-06-05 | 2023-11-08 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するための化合物 |
| MX2019015578A (es) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics Inc | Metodos para tratar la enfermedad de huntington. |
| MX2019015580A (es) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics Inc | Metodos para tratar la enfermedad de huntington. |
| JP7399870B2 (ja) | 2018-03-27 | 2023-12-18 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するための化合物 |
| EA202092899A1 (ru) | 2018-06-27 | 2021-05-14 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Гетероарильные соединения для лечения болезни гентингтона |
| LT3814357T (lt) | 2018-06-27 | 2024-06-25 | Ptc Therapeutics, Inc. | Heterocikliniai ir heteroarilų junginiai, skirti hantingtono ligos gydymui |
| US11685746B2 (en) | 2018-06-27 | 2023-06-27 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating Huntington's disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1574806A (en) * | 1976-06-03 | 1980-09-10 | Inverni Della Beffa Spa | Production of purified ginseng extracts and pharmaceutical compositions containing the extracts |
| GB8903804D0 (en) * | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB9016978D0 (en) * | 1990-08-02 | 1990-09-19 | Ici Plc | Acetamide derivatives |
| FR2746035B1 (fr) * | 1996-03-15 | 1998-06-12 | Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications | |
| DE69725320T2 (de) * | 1996-08-02 | 2004-07-15 | Plum Kemi Produktion A/S | Oel-im-wasser emulsion zur gruendlichen reinigung, zum schutz oder verbesserung der haut |
| JP3873097B2 (ja) * | 1997-11-06 | 2007-01-24 | 独立行政法人理化学研究所 | 抗肥満剤及び脂質代謝改善剤 |
| US6911441B2 (en) * | 2002-12-16 | 2005-06-28 | Akzo Nobel N.V. | Prolonged release pharmaceutical composition |
| JP4970932B2 (ja) * | 2003-03-11 | 2012-07-11 | トロフォ | コレスト−４−エン−３−オンの誘導体の医薬としての使用、これらを含む医薬組成物、新規誘導体及びそれらの製造方法 |
-
2007
- 2007-03-28 FR FR0702247A patent/FR2914188B1/fr not_active Expired - Fee Related
-
2008
- 2008-03-26 CA CA2680433A patent/CA2680433C/fr not_active Expired - Fee Related
- 2008-03-26 AU AU2008252830A patent/AU2008252830B2/en not_active Ceased
- 2008-03-26 JP JP2010500316A patent/JP5519488B2/ja active Active
- 2008-03-26 DK DK08787851.8T patent/DK2124961T3/da active
- 2008-03-26 ES ES08787851.8T patent/ES2454268T3/es active Active
- 2008-03-26 BR BRPI0808945-0A patent/BRPI0808945A2/pt not_active Application Discontinuation
- 2008-03-26 PL PL08787851T patent/PL2124961T3/pl unknown
- 2008-03-26 MX MX2009010372A patent/MX2009010372A/es active IP Right Grant
- 2008-03-26 EP EP08787851.8A patent/EP2124961B1/fr not_active Not-in-force
- 2008-03-26 WO PCT/FR2008/000406 patent/WO2008142231A2/fr not_active Ceased
- 2008-03-26 US US12/593,441 patent/US20100099652A1/en not_active Abandoned
- 2008-03-26 RU RU2009139755/15A patent/RU2462250C2/ru not_active IP Right Cessation
- 2008-03-26 PT PT87878518T patent/PT2124961E/pt unknown
- 2008-03-26 NZ NZ579632A patent/NZ579632A/en not_active IP Right Cessation
-
2009
- 2009-09-09 ZA ZA200906271A patent/ZA200906271B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010522729A (ja) | 2010-07-08 |
| BRPI0808945A2 (pt) | 2014-08-26 |
| NZ579632A (en) | 2012-05-25 |
| EP2124961A2 (fr) | 2009-12-02 |
| FR2914188A1 (fr) | 2008-10-03 |
| JP5519488B2 (ja) | 2014-06-11 |
| AU2008252830A1 (en) | 2008-11-27 |
| FR2914188B1 (fr) | 2012-06-22 |
| CA2680433A1 (fr) | 2008-11-27 |
| WO2008142231A3 (fr) | 2009-02-12 |
| WO2008142231A2 (fr) | 2008-11-27 |
| AU2008252830B2 (en) | 2013-08-15 |
| RU2009139755A (ru) | 2011-05-10 |
| PT2124961E (pt) | 2014-04-24 |
| ES2454268T3 (es) | 2014-04-10 |
| EP2124961B1 (fr) | 2014-01-15 |
| RU2462250C2 (ru) | 2012-09-27 |
| CA2680433C (fr) | 2014-08-12 |
| DK2124961T3 (da) | 2014-04-14 |
| US20100099652A1 (en) | 2010-04-22 |
| ZA200906271B (en) | 2010-05-26 |
| PL2124961T3 (pl) | 2014-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009010372A (es) | Nueva composicion basada en oxima de cholest-4-en-3ona. | |
| WO2007127834A3 (en) | Compositions and methods of preparation thereof | |
| EP4537849A3 (en) | Pharmaceutical compositions containing clostridium difficile toxoids a and b | |
| WO2007117556A3 (en) | Pharmaceutical compositions and uses thereof | |
| WO2008121767A3 (en) | Stitched polypeptides | |
| WO2008060705A3 (en) | Anti-dll4 antibodies and methods using same | |
| WO2008002674A3 (en) | Bicyclic compositions and methods for modulating a kinase cascade | |
| WO2009009041A3 (en) | Compositions and methods for modulating a kinase cascade | |
| WO2008149345A3 (en) | Tri-aryl compounds and compositions comprising the same | |
| WO2008130372A3 (en) | Production of sterols in oleaginous yeast and fungi | |
| WO2008112939A3 (en) | Composition and method for making oligo-benzamide compounds | |
| MX2009013199A (es) | Anticuerpos anti-notch1 nnr y sus metodos de uso. | |
| WO2009047644A3 (en) | Method of treating vitamin d insufficiency and deficiency | |
| WO2009152356A3 (en) | Compounds and compositions useful for the treatment of malaria | |
| WO2011072099A3 (en) | Compositions and methods comprising protease variants | |
| UA97502C2 (ru) | Кристаллическая твердая основа разагилина | |
| WO2008100805A3 (en) | Anti-robo4 antibodies and uses therefor | |
| WO2008124660A3 (en) | Methods and compositions for the treatment of cancer | |
| EP2535058A3 (en) | Stabilization of vaccines by lyophilization | |
| WO2007130697A3 (en) | Anti-ephb4 antibodies and methods using same | |
| WO2010049454A3 (en) | Antimicrobial composition from copepods | |
| WO2008027600A3 (en) | Imatinib compositions | |
| UA97369C2 (ru) | Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе | |
| WO2009047794A3 (en) | Docetaxel injectable composition, being absolutely free of ethanol | |
| MY149433A (en) | Nutritional compositions containing punicalagins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |